Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Comparative analysis of natalizumab versus fingolimod as second-line treatment in relapsing-remitting multiple sclerosis.

Lorscheider J, Benkert P, Lienert C, Hänni P, Derfuss T, Kuhle J, Kappos L, Yaldizli Ö.

Mult Scler. 2018 May;24(6):777-785. doi: 10.1177/1352458518768433. Epub 2018 Apr 24.

PMID:
29685071
2.

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.

Kuhle J, Hardmeier M, Disanto G, Gugleta K, Ecsedi M, Lienert C, Amato MP, Baum K, Buttmann M, Bayas A, Brassat D, Brochet B, Confavreux C, Edan G, Färkkilä M, Fredrikson S, Frontoni M, D'Hooghe M, Hutchinson M, De Keyser J, Kieseier BC, Kümpfel T, Rio J, Polman C, Roullet E, Stolz C, Vass K, Wandinger KP, Kappos L; European Long-term Follow-up Study Group in Interferon β-1b in Secondary-progressive Multiple Sclerosis.

Mult Scler. 2016 Apr;22(4):533-43. doi: 10.1177/1352458515594440. Epub 2015 Sep 11.

PMID:
26362898
3.

On the origin of Neurostatus.

Kappos L, D'Souza M, Lechner-Scott J, Lienert C.

Mult Scler Relat Disord. 2015 May;4(3):182-5. doi: 10.1016/j.msard.2015.04.001. Epub 2015 Apr 11. No abstract available.

PMID:
26008933
4.

Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease.

Lienert C, Schawalder G, Findling O, Kamm CP, Humpert S, Mugglin A, Mathis J, Sturzenegger M, Mattle HP.

Swiss Med Wkly. 2013 May 28;143:w13783. doi: 10.4414/smw.2013.13783. eCollection 2013.

5.

Trunk sway in mildly disabled multiple sclerosis patients with and without balance impairment.

Findling O, Sellner J, Meier N, Allum JH, Vibert D, Lienert C, Mattle HP.

Exp Brain Res. 2011 Sep;213(4):363-70. doi: 10.1007/s00221-011-2795-8. Epub 2011 Jul 20.

PMID:
21773798
6.

Infantile spasms: does season influence onset and long-term outcome?

Perret EV, von Elm E, Lienert C, Steinlin M.

Pediatr Neurol. 2010 Aug;43(2):92-6. doi: 10.1016/j.pediatrneurol.2010.03.006.

PMID:
20610118
7.

SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology.

Kamm CP, Mattle HP; SWABIMS Study Group.

Trials. 2009 Dec 14;10:115. doi: 10.1186/1745-6215-10-115.

8.

[Cerebral vasculitis].

Lienert C, Sturzenegger M.

Ther Umsch. 2008 May;65(5):259-63. doi: 10.1024/0040-5930.65.5.259. Review. German.

PMID:
18622929
9.

Clinical and immune responses correlate in glatiramer acetate therapy of multiple sclerosis.

Weder C, Baltariu GM, Wyler KA, Gober HJ, Lienert C, Schluep M, Radü EW, De Libero G, Kappos L, Duda PW.

Eur J Neurol. 2005 Nov;12(11):869-78.

PMID:
16241976
10.

An unusual cause of stridor in childhood due to focal epileptic seizures.

Wyder-Westh C, Lienert C, Pihan H, Steinlin M.

Eur J Pediatr. 2005 Oct;164(10):648-9. Epub 2005 Jun 15.

PMID:
15959802
11.

[Uric acid and multiple sclerosis].

Mattle HP, Lienert C, Greeve I.

Ther Umsch. 2004 Sep;61(9):553-5. Review. German.

PMID:
15493114
12.

Extraocular blood flow and endothelin-1 plasma levels in patients with multiple sclerosis.

Pache M, Kaiser HJ, Akhalbedashvili N, Lienert C, Dubler B, Kappos L, Flammer J.

Eur Neurol. 2003;49(3):164-8.

PMID:
12646761
13.

[Interferon beta-1b for treatment of secondary chronic progressive multiple sclerosis].

Zimmermann C, Walther EU, Goebels N, Lienert C, Kappos L, Hartung HP, Hohlfeld R.

Nervenarzt. 1999 Aug;70(8):759-63. German.

PMID:
10483579
14.

Use of composite scores in the quantification of deterioration in multiple sclerosis.

Lienert C, Lechner-Scott J, Schött D, Constantinescu C, Kappos L.

Mult Scler. 1999 Aug;5(4):220-2. Review. No abstract available.

PMID:
10467379
15.

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L.

Brain. 1998 Dec;121 ( Pt 12):2327-34.

PMID:
9874483

Supplemental Content

Loading ...
Support Center